79 related articles for article (PubMed ID: 2844067)
1. 1,25(OH)2D levels in dihydrotachysterol-treated patients: influence on 1,25(OH)2D assays.
Taylor A; Norman ME
J Bone Miner Res; 1987 Dec; 2(6):567-70. PubMed ID: 2844067
[TBL] [Abstract][Full Text] [Related]
2. Comparisons between two receptor assays for 1,25-dihydroxyvitamin D.
Hartwell D; Christiansen C
Scand J Clin Lab Invest; 1988 Apr; 48(2):109-14. PubMed ID: 2833812
[TBL] [Abstract][Full Text] [Related]
3. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
[TBL] [Abstract][Full Text] [Related]
4. Current therapy of hypoparathyroidism--a survey of German endocrinology centers.
Schilling T; Ziegler R
Exp Clin Endocrinol Diabetes; 1997; 105(4):237-41. PubMed ID: 9285213
[TBL] [Abstract][Full Text] [Related]
5. Serum dihydrotachysterol levels and biological action in normal man.
Taylor A; Bikle DD; Norman ME
J Clin Endocrinol Metab; 1988 Jul; 67(1):198-202. PubMed ID: 3379133
[TBL] [Abstract][Full Text] [Related]
6. In vivo dihydrotachysterol2 metabolism in normal man: 1 alpha- and 1 beta-hydroxylation of 25-hydroxydihydrotachysterol2 and effects on plasma parathyroid hormone and 1 alpha,25-dihydroxyvitamin D3 concentrations.
Schroeder NJ; Trafford DJ; Cunningham J; Jones G; Makin HL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1481-7. PubMed ID: 8200953
[TBL] [Abstract][Full Text] [Related]
7. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
[TBL] [Abstract][Full Text] [Related]
8. Gross and separative determination of 1 alpha,25-dihydroxyvitamin D2 and D3 in plasma using calf thymus receptor.
Masuda S; Okano T; Matsuoka S; Kobayashi T
J Nutr Sci Vitaminol (Tokyo); 1993 Apr; 39(2):101-14. PubMed ID: 8410371
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of exogenous 1,25-dihydroxyvitamin D [1,25-(OH)2D] versus endogenous 1,25-(OH)2D, induced by dietary calcium restriction, on vitamin D receptors.
Goff JP; Reinhardt TA; Beckman MJ; Horst RL
Endocrinology; 1990 Feb; 126(2):1031-5. PubMed ID: 2153516
[TBL] [Abstract][Full Text] [Related]
10. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.
Quack I; Zwernemann C; Weiner SM; Sellin L; Henning BF; Waldherr R; Büchner NJ; Stegbauer J; Vonend O; Rump LC
Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):376-80. PubMed ID: 16025398
[TBL] [Abstract][Full Text] [Related]
11. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
[No Abstract] [Full Text] [Related]
12. Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol.
Hymes LC; Warshaw BL
Am J Dis Child; 1984 Dec; 138(12):1125-8. PubMed ID: 6548870
[TBL] [Abstract][Full Text] [Related]
13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
14. Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.
Cordy PE
Can Med Assoc J; 1977 Oct; 117(7):766-8. PubMed ID: 907948
[TBL] [Abstract][Full Text] [Related]
15. Estimation of 1,25 dihydroxyvitamin D by cytoreceptor and competitive protein binding assays without high pressure liquid chromatography.
Nicholson GC; Kent JC; Gutteridge DH; Retallack RW
Clin Endocrinol (Oxf); 1985 May; 22(5):597-609. PubMed ID: 2992845
[TBL] [Abstract][Full Text] [Related]
16. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
Van Kesteren RG; Duursma SA; Dorhout Mees EJ
Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
[No Abstract] [Full Text] [Related]
17. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
Chesney RW; Hamstra AJ; Phelps M; DeLuca HF
Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
[TBL] [Abstract][Full Text] [Related]
18. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.
Reinhardt TA; Horst RL; Orf JW; Hollis BW
J Clin Endocrinol Metab; 1984 Jan; 58(1):91-8. PubMed ID: 6605973
[TBL] [Abstract][Full Text] [Related]
19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation.
Caplan RH; Beguin EA
Obstet Gynecol; 1990 Sep; 76(3 Pt 2):485-9. PubMed ID: 2381632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
